Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number5231
JournalCancer Research
Volume80
Issue numberSuppl.16
DOIs
Publication statusPublished - 15 Aug 2020
EventAnnual Meeting of the American Association for Cancer Research (AACR) 2020 - Philadelphia, United States
Duration: 22 Jun 202024 Jun 2020

Cite this